Abstract Introduction: Contrast-enhanced computed tomography (CT) has become the 'gold-standard' imaging modality for surveillance following EVAR. However repeated CT causes cumulative contrast related renal injury. Duplex ultrasound (USS) and contrast-enhanced (nonnephrotoxic) duplex scanning (CEUS) are less invasive but considered less accurate than CT. The aim of this study was to determine the diagnostic accuracy of imaging modalities used to detect endoleak. Accordingly, we undertook a systematic review and meta-analysis of the evidence base for USS and CEUS compared to CT following EVAR. Methods: Medline, Embase, trial registries, conference proceedings and article reference lists were searched to identify trials comparing USS or CEUS with CT following EVAR. Contrastenhanced computed tomography was taken as the 'gold-standard' investigation. USS and CEUS were compared to CT in separate meta-analyses. Results: Twenty-one studies in 2601 patients compared USS with CT. some caution due to heterogeneity in analysed trials and further research is needed to evaluate the efficacy of CEUS before it can be utilised as the primary imaging modality for EVAR surveillance. ª
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Introduction
Endovascular aneurysm repair (EVAR) was first described in 1991 1 and is associated with fewer cardiac, respiratory, and hemorrhagic complications than open aneurysm repair and requires a shorter hospital stay. 2 Subsequently, high-quality evidence has demonstrated favourable short-term mortality benefits for EVAR compared to open repair. 3 However, endoleak, migration and other endograft related complications following EVAR require long-term post-operative surveillance. The importance of these long-term risks is highlighted by recently presented data from the DREAM trial that shows greater 5-year post-discharge mortality in patients treated by EVAR compared with those undergoing open aneurysm repair. 4 Endoleak in particular carries great significance, as it is predictive of post-EVAR rupture, 5 and therefore, post-EVAR endoleak surveillance has become mandatory.
Endoleak is defined as the flow of blood within the aneurysm sac but outside the endovascular graft. At present contrast-enhanced spiral computed tomography (CT) angiography with specialized 3D reconstruction is considered as the gold-standard for endoleak surveillance. 6 CT angiography is efficient in defining the anatomy of aneurysm sac, detection of endoleak and its classification but factors such as a high dose of radiation with risk of skin malignancy, 7 administration of nephrotoxic contrast 8 and high cost 9 are the main limitations of its use as a lifelong surveillance tool.
Duplex ultrasound is being investigated as an alternative to CT for the follow-up of EVAR patients. This modality is less expensive and does not carry the risks associated with ionizing radiation or contrast induced nephrotoxicity. Researchers have also augmented duplex ultrasound with non-nephrotoxic contrast agents to detect post-EVAR endoleak and have claimed promising results. 10, 11 The aim of this meta-analysis is to update the sensitivity and specificity values of duplex ultrasound and contrastenhanced duplex ultrasound in comparison to CT, which remains the existing gold-standard for endoleak detection.
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Methods
An electronic search was performed using the Embase and Medline databases from 1996 until 2009, to identify studies comparing concurrent CT and USS for the detection of endoleak after EVAR. The search terms ''USS'', ''CT'', ''vascular'', ''EVAR'', ''endoleak' ' Contrast-enhanced computed tomography was taken as the 'gold-standard' investigation. Standard duplex ultrasound and contrast-enhanced duplex ultrasound were compared to CT in separate meta-analyses. Inclusion criteria comprised English language studies which reported the detection of endoleak in greater than 10 concurrent USS and CT examinations of unselected patients after EVAR. For inclusion, all studies had to provide sufficient individual patient data to allow the determination of both true and false positives and negatives in 2 Â 2 contingency tables. Study retrieval was conducted according to the QUORUM protocol (QUORUM diagram). Studies which had insufficient data to enable generation of contingency tables were excluded, and the QUADAS scoring tool 14 was used in duplicate by two authors (TAM and AK) for quality assessment. Where necessary, differences in QUADAS score were resolved by a third reviewer (JB).
Statistical analysis
A sensitivity and specificity pair was calculated for each eligible study. Initial meta-analysis was conducted using a fixed-effects model and the sensitivityespecificity pairs for each study were then plotted graphically to generate a summary receiver operating characteristic (ROC) curve. The area under the curve, a global reflection of diagnostic accuracy with a theoretical range of 0e1, was calculated together with its standard error. Heterogeneity was assessed by means of the I 2 statistic. This initial statistical analysis was performed using Meta-DiSc Version 1. 4 15 from which all I 2 statistics quoted in this article were obtained. However, it has been suggested that a bivariate model for meta-analysis of statistical accuracy provides more accurate results. 16, 17 The primary analyses were therefore repeated following peer review, using bivariate metaanalysis with hierarchical summary ROC curve analysis following the validated methodology of Harbord et al. 16 to generate pooled point estimates for sensitivity and specificity with 95% confidence intervals, together with a hierarchical summary ROC curve. The software used for this analysis was a custom-designed statistical package developed by Harbord and Whiting. 18 Similar estimates were obtained, but somewhat wider confidence intervals resulted from these re-analyses, so we provide quantitative results from the bivariate model wherever this analyses was performed. In order to assess whether there is any evidence of publication bias, funnel plots were constructed and inspected for asymmetry.
Results
Unenhanced ultrasound
Twenty-one studies provided sufficient data for inclusion in this meta-analysis (Table 1) . Overall, unenhanced duplex was compared to the gold-standard of contrast-enhanced CT in 2601 patients. From the bivariate meta-analysis, 16 the pooled sensitivity was 0.77 (95% CI 0.64e0.86; I 2 Z 0.82) and pooled specificity was 0.94 (95% CI 0.88e0.97; I 2 Z 0.90) (Fig. 1) . The summary ROC curve plotted using fixed-effects meta-analysis had an area under the curve of 0.91 (standard error 0.03). Visual inspection of the funnel plot revealed no asymmetry to indicate statistical evidence of publication bias.
Enhanced ultrasound
Seven studies (285 patients) provided sufficient data for inclusion in this analysis (Table 2) . From the bivariate metaanalysis, 16 the pooled sensitivity was 0.98 (95% CI 0.90e 0.99; I 2 Z 0.32). The pooled specificity was 0.88 (95% CI 0.78e0.94; I 2 Z 0.67) (Fig. 2) . The summary ROC curve plotted using fixed-effects meta-analysis had an area under the curve of 0.96 (standard error 0.02). Visual inspection of the funnel plot revealed no asymmetry to indicate statistical evidence of publication bias.
Sensitivity analyses
To analyse for the confounding effect of CEUS equipment being more modern than unenhanced USS, sensitivity analysis was performed using Meta-DiSc in which studies published prior to 2003 were excluded. Fairly similar results were obtained for unenhanced ultrasound (pooled sensitivity 0.59; 95% CI 0.52e0.66; pooled specificity 0.93; 95% CI 0.92e 0.94) and contrast-enhanced ultrasound (pooled sensitivity 0.89; 95% CI 0.80e0.95; pooled specificity 0.94; 95% CI 0.89e 0.97). To analyse for a confounding effect of trials with poor QUADAS score (Table 3) , sensitivity analysis was performed with the lowest-scoring trial removed from analysis. 19 The resulting point estimates of pooled sensitivity and specificity were unchanged to two decimal places.
Discussion
The point estimates for pooled sensitivity and specificity from bivariate meta-analysis suggest that contrastenhanced ultrasound has superior sensitivity compared to unenhanced ultrasound for the detection of endoleak after EVAR. The higher area under the summary ROC curve for contrast-enhanced ultrasound also suggests that this modality is superior. However, these results must be interpreted with some caution. There is significant heterogeneity among the studies. This partly arises from inherent inter-and intra-observer variation in studies of diagnostic imaging techniques (ultrasound in particular is very operator dependent). It may also arise from variation in instrument quality, particularly in the earlier studies with less advanced ultrasound equipment. Furthermore, in two studies the ultrasound operator was not blinded to the results of post-operative CT scanning, and this information was unclear in six studies, introducing potential observer bias and lowering the QUADAS score of contributing trials (Table 3) . Few trials reported inter-observer variability for within-group consideration of the diagnostic accuracy of USS and no trials reported statistical comparison of CEUS with USS (Table 4) .
Five of the seven studies of contrast-enhanced ultrasound were published in 2003 onwards, compared to only 10 of the 21 studies of unenhanced ultrasound. This raises the possibility that more advanced instrumentation may Figure 1 Plot comparing sensitivity and specificity of ultrasound vs CT, illustrating weighted point estimates of individual studies, pooled point estimate from bivariate meta-analysis, hierarchical summary ROC curve and elliptical 95% confidence interval of pooled estimate. An initial systematic review of the diagnostic accuracy of ultrasound in the follow-up of EVAR was performed by Ashoke et al. 13 They highlighted that non-contrast duplex ultrasound lacks sufficient diagnostic accuracy for sole use in endoleak detection. However, this analysis did not include a consideration of contrast-enhanced ultrasound, and the evidence base for all modalities has since increased, warranting renewed analysis incorporating newer trials. Sun 12 published a systematic review highlighting initial studies that included contrast-enhanced ultrasound, and concluded that this promising modality warranted further study. Our updated meta-analysis provides a much-needed quantitative analysis of contrastenhanced ultrasound, incorporating three high-quality new studies 11, 20, 21 not previously included in systematic quantitative review. Furthermore, the present study represents the first bivariate meta-analysis of this topic conducted using optimal statistical methodology and dedicated software as recommended by Harbord et al. 16, 17 Ultrasound offers several potential advantages compared to CT, including lower cost, radiation exposure, shorter scan times and most importantly the absence of nephrotoxicity. However, poor performance of colour duplex ultrasound in endoleak detection may be due to patient factors such as unfavourable body habitus, coexistent pathology such as ascites, hernia or excessive intervening bowel gas; and graft factors such as echo reflection from the stent graft or slow endoleak flow. Conversely, previous research has suggested that many of these hindrances can be minimised by the use of ultrasonic contrast. 22 Indeed, the high false-positive rate of contrastenhanced ultrasound compared to CT may in fact represent its higher sensitivity in detection of true low-flow endoleaks. 10, 23 Furthermore, the ultrasonic microbubble contrast agents employed in studies reviewed (Table 2) are all safe agents with no known nephrotoxicity. 24 Post-EVAR surveillance is required to identify endoleak and graft migration, but ultimately to guide re-intervention and prevent rupture. The indication for re-intervention after EVAR is complex and depends on many characteristics not identifiable by USS or CEUS including graft migration and limb kinking. Post-deployment device migration has also been identified by the EUROSTAR group as a poor prognostic sign. 25 Stent-strut failure has been shown to be clinically insignificant. 26 EVAR significantly reduces aneurysm sac pressures.
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Mean intra-sac pressures reduce to 20% of mean arterial pressure (MAP) following endovascular exclusion. 28 A potential surveillance technique is therefore serial assessment of intra-sac pressure. Long-term non-invasive sac pressure monitoring has been shown to be feasible and durable 29 and such alternative modalities further add to the complexity of a complete consideration of the relationship Figure 2 Plot comparing sensitivity and specificity of contrast-enhanced ultrasound vs CT, illustrating weighted point estimates of individual studies, pooled point estimate from bivariate meta-analysis, hierarchical summary ROC curve and elliptical 95% confidence interval of pooled estimate. between surveillance and re-intervention after EVAR. A consideration of the utility of CEUS or USS as the sole imaging modality for direction of re-intervention after EVAR is therefore clearly beyond the scope of the present metaanalysis. Type II endoleak alone is increasingly managed conservatively, and a limitation of the present study is that separate analysis by subtype of endoleak was not conducted. Evidence suggests that the risk of post-EVAR re-intervention is heterogeneous and that identification of a high-risk subgroup requiring intensive surveillance will depend on further study of aneurysm morphology. 30, 31 In the light of these hypotheses, further study of the accuracy of CEUS for identifying type I and III endoleaks and its implications for reintervention will need quantification using prospective trial design. The methodological quality of included trials is a further theoretical limitation of this meta-analysis, as was its limitation to the English language literature. However, sensitivity analysis by removal of the trial with the lowest QUADAS score 19 did not alter the pooled point estimates. Therefore the inclusion of the trial with the lowest QUADAS score did not alter pooled analysis or the validity of this review. Publication bias remains an inherent weakness of all meta-analyses, but visual inspection of funnel plots suggested that it was not a major contributory factor. A limitation of the present analysis was the historical nature of many of the AAA endografts included in the analysed studies. However, this does not represent a significant limitation to the external validity of analysis regarding the accuracy of endoleak diagnosis by USS or CT.
Although contrast-enhanced CT remains the gold-standard, the cumulative renal injury sustained due to repeated nephrotoxic contrast agent administration is of great concern. Preservation of renal function is vital to favourable long-term outcomes following AAA repair. 32 Although EVAR attenuates the initial renal response associated with open aneurysm repair, 33 longer-term renal function undergoes greater deterioration following EVAR compared to open repair. 34 Recently, concerns have been raised that this longterm decline in renal function may be due to the repeated use of nephrotoxic contrast agents in mandatory CT followup of EVAR. 35 Contrast-enhanced ultrasound utilises a nonnephrotoxic contrast agent offering safer post-EVAR surveillance. However, to replace the current gold-standard for endoleak detection, any alternative imaging modality must accurately identify endoleak with high sensitivity and specificity. Our meta-analysis confirms the promise of contrast-enhanced ultrasound in this regard. Focussed prospective analysis of the sole use of CEUS as the diagnostic imaging modality for post-EVAR endoleak is required.
Conclusion
Although duplex ultrasound is often used to augment CT scanning in post-EVAR follow-up, evidence suggests it is unsuitable for sole use in endoleak detection after EVAR. Our study confirms that CEUS offers promise as a safe and sensitive modality for endoleak detection, potentially obviating the need for patient exposure to high radiation doses and nephrotoxic agents in recurrent CT imaging. However, a cautious approach is required due to the high degree of heterogeneity in the existing evidence. Furthermore, this modality cannot always be used to assess many important factors requiring re-intervention after EVAR including graft migration and endograft kinking. Further research is required to evaluate the clinical safety of CEUS and its utility in the direction of post-EVAR re-intervention before it can be recommended as the sole imaging modality after EVAR.
